Astute Medical specializes in improving patient outcomes by identifying and validating biomarkers through advanced technology. The company operates in the healthcare diagnostics market, primarily serving hospitals and clinical laboratories. Astute Medical's core product is a Test System that utilizes immunoassay technology to detect changes in biomarker measurements, which correlate with the risk of Acute Kidney Injury (AKI). The test is performed on a small cartridge that employs proprietary microfluidic engineering for sample processing, and the results are read by a bench-top Meter. The business model is based on the sale of these diagnostic tests and the associated equipment, as well as licensing its intellectual property. Revenue is generated through direct sales to healthcare providers and through partnerships with other medical technology companies. Astute Medical holds a robust portfolio of intellectual property, including over 30 published international patent applications, which protect its innovative processes and technologies in major markets such as the United States, Canada, Japan, China, India, and the European Union.

Keywords: biomarkers, immunoassay, AKI, diagnostics, microfluidic engineering, healthcare, clinical laboratories, intellectual property, patents, medical technology.